These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17005822)

  • 1. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
    Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
    Landman D; Bratu S; Quale J
    J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
    Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH
    Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced porin expression with EnvZ-OmpR, PhoPQ, BaeSR two-component system down-regulation in carbapenem resistance of Klebsiella Pneumoniae based on proteomic analysis.
    Zhang K; Liu L; Yang M; Chen C; Li X; Tian J; Luo C; Wang X; Wang M
    Microb Pathog; 2022 Sep; 170():105686. PubMed ID: 35917986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
    Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
    Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.
    García-Sureda L; Doménech-Sánchez A; Barbier M; Juan C; Gascó J; Albertí S
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4742-7. PubMed ID: 21807980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae.
    Zhang Y; Jiang X; Wang Y; Li G; Tian Y; Liu H; Ai F; Ma Y; Wang B; Ruan F; Rajakumar K
    Antimicrob Agents Chemother; 2014; 58(2):1214-7. PubMed ID: 24277031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Genetic Background of KPC-2-Producing
    Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
    Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
    Shen Z; Ding B; Ye M; Wang P; Bi Y; Wu S; Xu X; Guo Q; Wang M
    J Antimicrob Chemother; 2017 Jul; 72(7):1930-1936. PubMed ID: 28333323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
    Tian X; Wang Q; Perlaza-Jiménez L; Zheng X; Zhao Y; Dhanasekaran V; Fang R; Li J; Wang C; Liu H; Lithgow T; Cao J; Zhou T
    BMC Microbiol; 2020 Jul; 20(1):218. PubMed ID: 32689945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.